Want to join the conversation?
$NFLX 2Q15 10-Q: Revenues were $1,644.69MM vs. $1,340.41MM in 2Q14. Operating income was $74.84MM vs. $129.6MM in 2Q14. Net income was $26.34MM vs. $71.02MM in 2Q14. Diluted EPS was $0.06 vs. $0.16 per share in 2Q14. Comprehensive income was $31.37MM vs. $73.02MM in 2Q14.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.